GW441756

CAS : 504433-23-2

Ref. 3D-EVA43323

Informations sur le produit

• Nom: GW441756
• Marque: Biosynth
• Description: GW441756 is a specific agonist of the epidermal growth factor receptor that has been shown to inhibit bladder cancer and skin cancer. It can also reduce the severity of inflammatory bowel disease, infectious diseases, and skin cancer. GW441756 has been found to have antiinflammatory activity by inhibiting prostaglandin synthesis in the lung. This drug blocks signal pathways in cells by binding to specific receptors for growth factors such as epidermal growth factor (EGF) and neurotrophic factors. GW441756 binds to EGF receptors on the surface of cells in order to inhibit cell proliferation, which prevents cell cycle progression from G1 phase to S phase.GW441756 also induces apoptosis by binding with EGF receptors on the surface of cells and activating a signaling pathway that leads to activation of caspases, which are enzymes that cleave proteins into smaller fragments that are eventually degraded or eliminated from the cell.

Propriétés chimiques

• Masse moléculaire: 275.3 g/mol
• Formule: C₁₇H₁₃N₃O
• Degré de pureté: Min. 95%